SEC Filings
Kiniksa's Semi-Finished Drug Stock Hits $76.2 Million As Samsung Takes Over Manufacturing
Total ARCALYST inventory reached $112.7 million at September 30, up from $59.9 million at year-end, as sales climbed.
SEC Filings
Total ARCALYST inventory reached $112.7 million at September 30, up from $59.9 million at year-end, as sales climbed.
SEC Filings
The clinical research firm's backlog fell to $32.6 billion after it dropped inactive trials, while new 2034 notes carry a higher coupon.
SEC Filings
Operating cash flow hit $28.4 million as receivables unwound, while employee tax bills took $16.8 million and buybacks halved.
SEC Filings
The new unsecured facility matures October 21, 2031 and starts at 100 basis points over SOFR, with Bank of America as lead agent.
SEC Filings
The 10-Q splits the deal's earlier $140 million incentive pool into a $125 million earnout and a $15 million deferred payment.
SEC Filings
A Blackstone subsidiary priced $600 million of notes due 2031 and $500 million due 2033, backed by the parent and five Holdings partnerships.
SEC Filings
The card lender set the offering of 5,000,000 depositary shares at $25 each, with settlement scheduled for November 3, 2026.
SEC Filings
The iLet pump maker's new 10-Q promises cash only "for the foreseeable future" while a securities class action proceeds.
SEC Filings
John Douglas Arnold's Centaurus Capital certified it holds the Class A shares for investment, not to influence control of the geothermal developer.
SEC Filings
The asset manager reports sole voting power over 1.24 billion of the shares and says it has no aim to influence control.
SEC Filings
Cash from operations fell from $119.3 million a year earlier, and a $20.0 million net revolver draw helped fund repurchases.
SEC Filings
BlackRock holds 13,356,138 Wave shares as of September 30, while Wave posted a $61.9 million third-quarter net loss.